A Randomised, Double-Blind, Placebo-Controlled Study to Assess the Safety and Tolerability of PBT2, and its Effect on Amyloid Deposition in the Brains of Patients with Prodromal or Mild Alzheimer’s Disease (Protocol PBT2-204).
DEMENTIA TRIALS AUSTRALIA